查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1520468

2024-2032 年按產品、應用、最終用戶（學術和研究機構、製藥和生物技術公司、合約研究組織）和地區分類的糖組學市場報告

Glycomics Market Report by Product, Application, End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations ), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球糖組學市場規模達到15億美元。慢性病在大眾中日益流行、對糖工程技術的日益關注以及涉及藥物和生物製劑的合約研究組織（CRO）數量的增加是推動市場的一些主要因素。

糖組學是一個專注於生物系統中碳水化合物（特別是聚醣）的綜合研究的科學領域。它的目的是了解聚醣的結構、組成和功能，以及它們與其他生物分子的相互作用。透過分析醣組，研究人員可以確定聚醣如何影響生物過程以及對健康和疾病的影響。這個跨學科領域結合了化學、生物化學、分子生物學和資訊學的各個方面，以揭示聚醣結構和功能的複雜性。從研究中獲得的見解對各個領域都有影響，包括醫學、藥物開發、生物標記發現和個人化治療。

全球市場主要受到慢性病盛行率日益成長的推動。此外，對糖工程的日益關注正在支持市場，因為糖工程涉及對聚醣進行修飾或操作以用於各種應用，包括治療、疫苗和生物技術。除此之外，各國政府、研究組織和私人投資者正在認知到糖組學在推進醫療保健和生物技術方面的潛力，並提供投資以進行深入研究、開發新技術和探索基於糖組學的產品的商業化，從而提供了為市場帶來提振。此外，它在全球教育和培訓領域越來越受歡迎。此外，參與藥物和生物製品開發和生產的合約研究組織（CRO）數量不斷增加，也促進了市場的成長。其他因素，例如製藥業的擴張、臨床試驗數量的增加以及醫療保健基礎設施的進步，也在影響市場。

糖組學市場趨勢/促進因素：

增加研發活動

市場正在經歷研發 (R&D) 活動的顯著成長。人們對聚醣在各種生物過程中所發揮的關鍵作用的日益了解，增加了人們對研究和操縱這些分子的興趣。研究人員和製藥公司正在投資研究，探索聚醣在藥物發現、個人化醫療和診斷方面的潛在應用。此外，分析技術和技術的不斷進步推動了研究範圍的擴大。此外，學術界、工業界和研究機構之間的合作推動了糖組學研發的成長。這些合作匯集了不同的專業知識和資源，促進創新並加速基於糖組學的產品的開發。此外，各利益相關者之間的協作努力有助於知識的擴展、新技術的開發以及將研究成果轉化為實際應用。

對個人化醫療的需求不斷成長

個人化醫療旨在根據患者的基因組成和具體特徵為其製定治療方案，日益受到重視。它在個人化醫療中發揮關鍵作用，因為聚醣與多種疾病有關，並且可以作為診斷和預後的潛在生物標記。分析和了解患者糖組的能力可以促進標靶治療和更精確的醫療干預措施的發展。此外，醣組學分析技術（例如聚醣微陣列和聚醣測序）的進步促進了疾病特異性聚醣特徵的識別。這些發現為基於聚醣的診斷、個人化治療和伴隨診斷的發展帶來了希望，進一步推動了對糖組學研究和產品的需求。

日益關注生物標記的發現

糖組學在生物標記發現領域獲得了廣泛關注。聚醣作為多種疾病的生物標記顯示出巨大的潛力，包括癌症、心血管疾病和傳染病。生物標記在疾病診斷、預後和監測治療效果中發揮著至關重要的作用。此外，對生物標記發現的日益關注推動了對研究的需求，因為可靠且特異的生物標記物的鑑定對於改善疾病檢測、患者分層和治療選擇至關重要。此外，將糖組學整合到生物標記發現管道中，有可能徹底改變診斷並實現早期干預，從而推動整個市場的成長。此外，該研究還提供了一個獨特的機會來識別與不同疾病相關的特定聚醣模式或變化。透過研究個體或患者群體的醣組，研究人員可以揭示疾病特異性的聚醣特徵，可以作為診斷或預後生物標記。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球糖組學市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 酵素
    • 市場走向
    • 關鍵環節
      • 糖苷酶
      • 糖基轉移酶
      • 神經氨酸酶
      • 唾液酸轉移酶
      • 其他
    • 市場預測
  • 儀器
    • 市場走向
    • 關鍵環節
      • 質譜儀
      • 高效液相層析法
      • 飛行時間飛行時間
      • 陣列系統
      • 其他
    • 市場預測
  • 套件
    • 市場走向
    • 關鍵環節
      • 聚醣標記試劑盒
      • 聚醣純化試劑盒
      • 聚醣釋放套件
      • 其他
    • 市場預測
  • 試劑
    • 市場走向
    • 關鍵環節
      • 糖蛋白
      • 單醣
      • 寡糖
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 藥物發現與開發
    • 市場走向
    • 市場預測
  • 診斷
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 學術及研究機構
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 合約研究組織 (CRO)
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Danaher Corporation
    • Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
    • Merck KGaA
    • New England Biolabs
    • RayBiotech Life Inc.
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112024A5689

The global glycomics market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.17% during 2024-2032. The growing prevalence of chronic diseases among the masses, the rising focus on glycoengineering techniques, and the growing number of contract research organizations (CROs) involved in drug and biologics are some of the major factors propelling the market.

Glycomics is a scientific field that focuses on the comprehensive study of carbohydrates, specifically glycans, in biological systems. It aims to understand the structure, composition, and functions of glycans, as well as their interactions with other biomolecules. By analyzing the glycome, researchers can determine how glycans influence biological processes and contribute to health and disease. This interdisciplinary field combines aspects of chemistry, biochemistry, molecular biology, and informatics to unravel the complexities of glycan structures and functions. The insights gained from the research have implications across various domains, including medicine, drug development, biomarker discovery, and personalized therapeutics.

The global market is primarily driven by the growing prevalence of chronic diseases. Moreover, the increasing focus on glycoengineering is supporting the market as glycoengineering involves the modification or manipulation of glycans for various applications, including therapeutics, vaccines, and biotechnology. Apart from this, Governments, research organizations, and private investors are recognizing the potential of glycomics in advancing healthcare and biotechnology and are providing investments to conduct in-depth studies, develop new technologies, and explore the commercialization of glycomics-based products, providing a boost to the market. Furthermore, it is gaining popularity in the field of education and training worldwide. Additionally, the growing number of contract research organizations (CROs) involved in drug and biologics development and production is augmenting the market growth. Other factors, such as expanding pharmaceutical industry, increasing number of clinical trials, and advancements in healthcare infrastructure, are also influencing the market.

Glycomics Market Trends/Drivers:

Increasing Research and Development Activities

The market is experiencing a significant boost in research and development (R&D) activities. The growing understanding of the crucial roles played by glycans in various biological processes has increased interest in studying and manipulating these molecules. Researchers and pharmaceutical companies are investing in research to explore the potential applications of glycans in drug discovery, personalized medicine, and diagnostics. Moreover, the expanding scope of the research is driven by continuous advancements in analytical techniques and technologies. Furthermore, collaborations between academia, industry, and research institutions have fueled the growth of glycomics R&D. These collaborations bring together diverse expertise and resources, fostering innovation and accelerating the development of glycomics-based products. Additionally, the collaborative efforts between various stakeholders contribute to the expansion of knowledge, development of new technologies, and translation of research findings into practical applications.

Rising Demand for Personalized Medicine

Personalized medicine, which aims to tailor medical treatments to individual patients based on their genetic makeup and specific characteristics, is gaining prominence. It plays a pivotal role in personalized medicine as glycans have been implicated in various diseases and can serve as potential biomarkers for diagnostics and prognostics. The ability to analyze and understand the glycome of patients can enable the development of targeted therapies and more precise medical interventions. In addition, the advancements in glycomics profiling technologies, such as glycan microarrays and glycan sequencing, have facilitated the identification of disease-specific glycan signatures. These discoveries hold promise for the development of glycan-based diagnostics, personalized therapeutics, and companion diagnostics, further fueling the demand for glycomics research and products.

Increasing Focus on Biomarker Discovery

Glycomics has gained significant attention in the field of biomarker discovery. Glycans have shown promising potential as biomarkers for various diseases, including cancer, cardiovascular disorders, and infectious diseases. Biomarkers play a crucial role in disease diagnosis, prognosis, and monitoring treatment efficacy. Moreover, the growing focus on biomarker discovery has propelled the demand for research, as the identification of reliable and specific biomarkers is crucial for improving disease detection, patient stratification, and treatment selection. Furthermore, the integration of glycomics into biomarker discovery pipelines has the potential to revolutionize diagnostics and enable early intervention, driving the growth of the overall market. Also, the research offers a unique opportunity to identify specific glycan patterns or alterations associated with different diseases. By studying the glycome of individuals or patient cohorts, researchers can unveil disease-specific glycan signatures that can serve as diagnostic or prognostic biomarkers.

Glycomics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global glycomics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Enzymes

Glycosidases

Glycosyltransferases

Neuraminidases

Sialyltransferases

Others

Instruments

Mass Spectrometers

HPLC

MALDI-TOF

Array systems

Others

Kits

Glycan Labeling Kits

Glycan Purification Kits

Glycan Release Kits

Others

Reagents

Glycoproteins

Monosaccharides

Oligosaccharides

Others

Enzymes equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes enzymes (glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and others), instruments (mass spectrometers, HPLC, MALDI-TOF, array systems, and others), kits (glycan labeling kits, glycan purification kits, glycan release kits, and others), reagents (glycoproteins, monosaccharides, oligosaccharides, and others). According to the report, enzymes represented the largest segment.

On the basis of the product, enzymes represent the largest product segment within the market. Enzymes play a crucial role in research and applications by facilitating the analysis and manipulation of glycans. Enzymes, such as glycosidases, glycosyltransferases, and glycosyl hydrolases, are utilized in various workflows, including glycan release, structural analysis, and glycan modification. Moreover, enzymes are essential for the enzymatic cleavage of glycans from glycoproteins or glycolipids, enabling the analysis of liberated glycans. The demand for enzymes in research and applications is driven by the growing need for robust and efficient enzymatic tools. Researchers and scientists rely on enzymes to accurately and selectively manipulate glycans, enabling comprehensive glycomics analysis and the development of glycan-based products. Additionally, advancements in enzyme engineering and optimization have led to the development of highly specific and efficient enzymes, further enhancing their utility in glycomics research.

Breakup by Application:

Drug Discovery and Development

Diagnostics

Others

Drug discovery and development hold the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes drug discovery and development, diagnostics, and others. According to the report, drug discovery and development accounted for the largest market share.

On the basis of application, drug discovery and development represent the largest segment within the overall market. It plays a crucial role in advancing drug discovery and development processes by providing insights into the role of glycans in disease mechanisms, drug efficacy, and safety. Glycans are involved in various biological processes and have been linked to numerous diseases, including cancer, cardiovascular disorders, and infectious diseases. Understanding the glycan profiles and their interactions with proteins and cells is essential for identifying potential therapeutic targets and designing effective drugs. Moreover, the integration with drug discovery and development processes has led to the development of glycan-based therapies, companion diagnostics, and improved drug screening platforms. Also, the focus on targeting glycans in drug discovery and development has driven the demand for research and technologies, making it the largest application segment within the market.

Breakup by End User:

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Academic and research institutes hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). According to the report, academic and research institutes accounted for the largest market share.

Academic and research institutes represent the largest segment of the market. They play a vital role in driving research and advancements in the field. These institutions serve as the primary hubs for scientific research, knowledge generation, and innovation in the field. They are home to leading scientists, researchers, and experts who are actively involved in studying and exploring the complexities of glycans. These institutions also provide the necessary infrastructure, funding, and collaborative opportunities to support the research. They often house state-of-the-art laboratories equipped with advanced analytical instruments and technologies, enabling comprehensive glycan analysis and profiling. Furthermore, academic and research institutes contribute significantly to expanding the knowledge base through publications, scientific conferences, and collaborations. They foster interdisciplinary research collaborations, bringing together experts from various fields such as chemistry, biology, bioinformatics, and medicine.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest glycomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the market. North America is home to several renowned academic institutions, research organizations, and biotechnology companies that have made significant contributions to the research. These institutions have robust research infrastructure, state-of-the-art laboratories, and well-established collaborations, facilitating cutting-edge studies and innovation. Moreover, the region has a well-developed healthcare and biopharmaceutical sector, which drives the demand for research and applications. The presence of major pharmaceutical companies and biotech firms in North America leads to significant investments in the research for drug discovery, personalized medicine, and the development of glycan-based therapeutics. Furthermore, the region has a favorable regulatory environment and strong intellectual property protections that encourage innovation and commercialization of glycomics-based products. The region's well-defined regulatory frameworks provide clarity and guidance for research, ensuring the safety and efficacy of glycan-based diagnostics and therapeutics.

Competitive Landscape:

Companies in the market are involved in various activities related to glycomics research, product development, and commercialization. Several major companies are investing in research and development to advance the understanding of glycans, develop new technologies, and explore applications in various fields. They conduct studies to uncover the roles of glycans in disease mechanisms, identify glycan biomarkers, and understand glycan-protein interactions. Moreover, the companies in the market develop and manufacture products that support the research. This includes enzymes, kits, reagents, and instruments used in glycan analysis, glycan profiling, and glycan modification. These products help researchers in academia, pharmaceutical companies, and research institutes carry out glycomics experiments and investigations. Additionally, some companies focus on translating research into commercial applications. They develop and market glycan-based products for various industries, such as biopharmaceuticals, diagnostics, and nutraceuticals.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Asparia Glycomics

Bruker Corporation

Danaher Corporation

Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)

Merck KGaA

New England Biolabs

RayBiotech Life Inc.

Shimadzu Corporation

Takara Bio Inc.

Thermo Fisher Scientific Inc.

Waters Corporation.

Recent Developments:

In June 2023, Agilent Technologies Inc. launched Agilent BioTek 406 FX washer dispenser, a compact instrument that combines multifunctional reagent dispensing and plate-washing capabilities. The BioTek 406 FX offers expanded liquid handling features designed for integration into automated systems and standalone benchtop use.

In March 2023, Waters Corporation launched Next-Generation Alliance iS HPLC System aimed at reducing Up to 40% of Common Lab Errors. This new product helps laboratories manage operational risk, mitigate disruptions, and increase overall productivity.

In September 2022, Thermo Fisher Scientific Inc. launched the DynaSpin(TM) Single-Use Centrifuge system2. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. It also improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process.

Key Questions Answered in This Report

  • 1. What was the size of the global glycomics market in 2023?
  • 2. What is the expected growth rate of the global glycomics market during 2024-2032?
  • 3. What are the key factors driving the global glycomics market?
  • 4. What has been the impact of COVID-19 on the global glycomics market?
  • 5. What is the breakup of the global glycomics market based on the product?
  • 6. What is the breakup of the global glycomics market based on the application?
  • 7. What is the breakup of the global glycomics market based on end user?
  • 8. What are the key regions in the global glycomics market?
  • 9. Who are the key players/companies in the global glycomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Glycomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Enzymes
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Glycosidases
      • 6.1.2.2 Glycosyltransferases
      • 6.1.2.3 Neuraminidases
      • 6.1.2.4 Sialyltransferases
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Mass Spectrometers
      • 6.2.2.2 HPLC
      • 6.2.2.3 MALDI-TOF
      • 6.2.2.4 Array systems
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Kits
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Glycan Labeling Kits
      • 6.3.2.2 Glycan Purification Kits
      • 6.3.2.3 Glycan Release Kits
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Reagents
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Glycoproteins
      • 6.4.2.2 Monosaccharides
      • 6.4.2.3 Oligosaccharides
      • 6.4.2.4 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Academic and Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Asparia Glycomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 New England Biolabs
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 RayBiotech Life Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Shimadzu Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Waters Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Glycomics Market: Major Drivers and Challenges
  • Figure 2: Global: Glycomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Glycomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Glycomics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Glycomics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Glycomics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Glycomics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Glycomics (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Glycomics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Glycomics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Glycomics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Glycomics (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Glycomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Glycomics Industry: SWOT Analysis
  • Figure 78: Global: Glycomics Industry: Value Chain Analysis
  • Figure 79: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Glycomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Glycomics Market: Competitive Structure
  • Table 7: Global: Glycomics Market: Key Players